These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals. Govan B; Ketheesan N Clin Microbiol Infect; 2004 Jun; 10(6):585-7. PubMed ID: 15191392 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice. Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294 [TBL] [Abstract][Full Text] [Related]
26. An ultrastructural study of the phagocytosis of Burkholderia pseudomallei. Harley VS; Dance DA; Tovey G; McCrossan MV; Drasar BS Microbios; 1998; 94(377):35-45. PubMed ID: 9785484 [TBL] [Abstract][Full Text] [Related]
27. The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells. Boddey JA; Day CJ; Flegg CP; Ulrich RL; Stephens SR; Beacham IR; Morrison NA; Peak IR Cell Microbiol; 2007 Feb; 9(2):514-31. PubMed ID: 16987331 [TBL] [Abstract][Full Text] [Related]
29. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Healey GD; Elvin SJ; Morton M; Williamson ED Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315 [TBL] [Abstract][Full Text] [Related]
30. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. Gilmore G; Barnes J; Ketheesan N; Norton R Clin Vaccine Immunol; 2007 Nov; 14(11):1529-31. PubMed ID: 17804613 [TBL] [Abstract][Full Text] [Related]
31. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Santanirand P; Harley VS; Dance DA; Drasar BS; Bancroft GJ Infect Immun; 1999 Jul; 67(7):3593-600. PubMed ID: 10377144 [TBL] [Abstract][Full Text] [Related]
32. Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide. Chantratita N; Tandhavanant S; Myers ND; Seal S; Arayawichanont A; Kliangsa-Ad A; Hittle LE; Ernst RK; Emond MJ; Wurfel MM; Day NP; Peacock SJ; West TE PLoS One; 2013; 8(11):e81617. PubMed ID: 24303060 [TBL] [Abstract][Full Text] [Related]
33. Hijacking of the Host's Immune Surveillance Radars by Mariappan V; Vellasamy KM; Barathan M; Girija ASS; Shankar EM; Vadivelu J Front Immunol; 2021; 12():718719. PubMed ID: 34456925 [No Abstract] [Full Text] [Related]
34. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity. Lazzaroni SM; Barnes JL; Williams NL; Govan BL; Norton RE; LaBrooy JT; Ketheesan N Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S66-70. PubMed ID: 19121692 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid A structure and TLR4-dependent innate immune activation. Sengyee S; Yoon SH; Paksanont S; Yimthin T; Wuthiekanun V; Limmathurotsakul D; West TE; Ernst RK; Chantratita N PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006287. PubMed ID: 29474381 [TBL] [Abstract][Full Text] [Related]
36. The humoral immune response in melioidosis patients during therapy. Vasu C; Vadivelu J; Puthucheary SD Infection; 2003 Jan; 31(1):24-30. PubMed ID: 12590329 [TBL] [Abstract][Full Text] [Related]
37. Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM. Tan KS; Chen Y; Lim YC; Tan GY; Liu Y; Lim YT; Macary P; Gan YH J Immunol; 2010 May; 184(9):5160-71. PubMed ID: 20335533 [TBL] [Abstract][Full Text] [Related]
38. Burkholderia pseudomallei: animal models of infection. Titball RW; Russell P; Cuccui J; Easton A; Haque A; Atkins T; Sarkar-Tyson M; Harley V; Wren B; Bancroft GJ Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S111-6. PubMed ID: 19121670 [TBL] [Abstract][Full Text] [Related]
39. Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions. Buddhisa S; Rinchai D; Ato M; Bancroft GJ; Lertmemongkolchai G J Immunol; 2015 May; 194(9):4413-21. PubMed ID: 25801435 [TBL] [Abstract][Full Text] [Related]